Evidence map›Paper›PMID 25726747›Full record

ArticleNeurobiology of disease2015

Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury.

Vera Valakh, Erin Frey, Elisabetta Babetto, Lauren J Walker, Aaron DiAntonio

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. A tubulin-MAPKKK pathway engages tubulin isotype interaction for neuroprotection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vera ValakhDepartment of Developmental Biology, Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO 63110, USA.
Erin FreyDepartment of Developmental Biology, Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO 63110, USA.
Elisabetta BabettoDepartment of Developmental Biology, Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO 63110, USA.
Lauren J WalkerDepartment of Developmental Biology, Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO 63110, USA.
Aaron DiAntonioDepartment of Developmental Biology, Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO 63110, USA. Electronic address: diantonio@wustl.edu.
Hope Center for Neurological Disorders · US

Funding

Regulation of axonal degeneration by the DLK kinaseR37NS065053 · NINDS · WASHINGTON UNIVERSITY · PI Aaron Diantonio · 2020 to 2026
$4.3M
MOLECULAR PATHWAYS REGULATING SYNAPTIC GROWTHR01DA020812 · NIDA · WASHINGTON UNIVERSITY · PI DIANTONIO, AARON · 2007 to 2016
$3.3M
REGULATION OF AXONAL DEGENERATION BY THE DLK KINASER01NS065053 · NINDS · WASHINGTON UNIVERSITY · PI DIANTONIO, AARON · 2010 to 2019
$3.3M
A HIGH-THROUGHPUT ASSAY FOR PRECONDITIONING FACTORS THAT PROMOTE AXONAL REGENERATR33NS087562 · NINDS · WASHINGTON UNIVERSITY · PI DIANTONIO, AARON, MILBRANDT, JEFFREY D · 2016 to 2017
$1.1M
A HIGH-THROUGHPUT ASSAY FOR PRECONDITIONING FACTORS THAT PROMOTE AXONAL REGENERATR21NS087562 · NINDS · WASHINGTON UNIVERSITY · PI DIANTONIO, AARON, MILBRANDT, JEFFREY D · 2014 to 2015
$418k
NIDA NIH HHS DA020812NIDA NIH HHS R01 DA020812NINDS NIH HHS NS065053NINDS NIH HHS NS087562NINDS NIH HHS R01 NS065053NINDS NIH HHS R21 NS087562NINDS NIH HHS R33 NS087562NINDS NIH HHS R37 NS065053
6 · The paper itself

Abstract

Nerve injury can lead to axonal regeneration, axonal degeneration, and/or neuronal cell death. Remarkably, the MAP3K dual leucine zipper kinase, DLK, promotes each of these responses, suggesting that DLK is a sensor of axon injury. In Drosophila, mutations in proteins that stabilize the actin and microtubule cytoskeletons activate the DLK pathway, suggesting that DLK may be activated by cytoskeletal disruption. Here we test this model in mammalian sensory neurons. We find that pharmacological agents designed to disrupt either the actin or microtubule cytoskeleton activate the DLK pathway, and that activation is independent of calcium influx or induction of the axon degeneration program. Moreover, activation of the DLK pathway by targeting the cytoskeleton induces a pro-regenerative state, enhancing axon regeneration in response to a subsequent injury in a process akin to preconditioning. This highlights the potential utility of activating the DLK pathway as a method to improve axon regeneration. Moreover, DLK is required for these responses to cytoskeletal perturbations, suggesting that DLK functions as a key neuronal sensor of cytoskeletal damage.

Indexed as

AnimalsCalcium-Binding ProteinsCells, CulturedChelating AgentsCytochalasin DCytoskeletonEmbryo, MammalianEnzyme ActivationEnzyme InhibitorsFemaleGanglia, SpinalIntercellular Signaling Peptides and ProteinsMaleMAP Kinase Kinase 4MAP Kinase Signaling SystemMiceCalcium-Binding ProteinsChelating AgentsCytochalasin DDlk1 protein, mouseEnzyme InhibitorsIntercellular Signaling Peptides and ProteinsMAP Kinase Kinase 4NocodazoleAxon regrowthCytoskeletonDLKDRGNeuronNeuropathyRegeneration

Identifiers

PMID25726747
PMCPMC4402261
OpenAlexW2049474406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.